Dos and Don'ts that are Issued through Radiolabeling Process of DMSA (Dimercaptosuccinic Acid) by 99mTco4- as 99mTc-DMSA(III), the Gold Standard Radiopharmaceutical for Renal Cortical Scintigraphy

Dos and Don'ts that are Issued through Radiolabeling Process of DMSA (Dimercaptosuccinic Acid) by 99mTco4- as 99mTc-DMSA(III), the Gold Standard Radiopharmaceutical for Renal Cortical Scintigraphy


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: اشرف فخاری , اسماعیل قره پاپاق , شهرام دبیری اسکوئی

کلمات کلیدی: Radiolabeling; 99mTc- DMSA; Renal scintigraphy; Renal pharmaceuticals

نشریه: 0 , 2 , 9 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله اشرف فخاری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه تیم های تحقیقاتی دانشگاه
کد مقاله 63756
عنوان فارسی مقاله Dos and Don'ts that are Issued through Radiolabeling Process of DMSA (Dimercaptosuccinic Acid) by 99mTco4- as 99mTc-DMSA(III), the Gold Standard Radiopharmaceutical for Renal Cortical Scintigraphy
عنوان لاتین مقاله Dos and Don'ts that are Issued through Radiolabeling Process of DMSA (Dimercaptosuccinic Acid) by 99mTco4- as 99mTc-DMSA(III), the Gold Standard Radiopharmaceutical for Renal Cortical Scintigraphy
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق) Journal of Nuclear Medicine & Radiation Therapy
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح چهار – Index Copernicus
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract Objective: Since DMSA (Dimercaptosuccinic Acid) is an important and more sensitive kit in the realm of renal scintigraphy, in the course of this enormous study throughout five years, all quality control results from more than 500 Tc-99m radiolabeled DMSA kits and scans were studied to improve radiolabeling method through optimization of all involving parameters. Methods: Instant thin layer chromatography (ITLC) (support: ITLC-Silicic-acid (SA), solvent: n-Butanol Saturated with 0.3N HCl) were used to calculate %radiochemical purity (%Tc-99m DMSA). Data from ITLC and scans were investigated to obtain the optimized radiolabeling method so as to decrease background uptake particularly liver uptake. Results: Data suggested that if radiolabeling is performed under optimized involving parameters (Generator used day 2, SA=(15-20 mCi)/ (1cc) radiochemical purity=99.5% (Al2O3<5 ppm), generator’s pH=4-4.5), the % Tc-99m dimercaptosuccinic acid (DMSA) will be ≥ 90-95%. Moreover, more intricate scans with abnormal biodistribution of radiotracer developed the expanded view on 99mTc-DMSA(III) renal scan impression with regard to diseases that can affect the 99mTc-DMSA(III) biodistribution. During this investigation, it was concluded that almost all diseases that influence liver and spleen including fatty liver, mononucleosis and similar illnesses could change routine biodistribution of 99mTc-DMSA(III). Conclusion: Finally, we suggested an optimized radiolabeling method 99mTc-DMSA(III) ≥ 90-95%) to reach a precious imaging as more as we can decrease uncertainties about interpretation of Tc-99m DMSA scan considering patient’s background to provide an effective diagnosis.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
اشرف فخاریاول
اسماعیل قره پاپاقسوم
شهرام دبیری اسکوئیچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
dos-and-donts-that-are-issued-through-radiolabeling-process-of-dmsadimercaptosuccinic-acid-by-99mtco4-as-99mtcdmsaiii-the-goldstan-2155-9619-1000363.pdf1397/06/10844751دانلود